Published in Heart Rhythm on May 19, 2008
Cardiac resynchronization therapy: a meta-analysis of randomized controlled trials. CMAJ (2011) 2.28
Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol (2011) 1.46
Cardiac MRI scar patterns differ by sex in an implantable cardioverter-defibrillator and cardiac resynchronization therapy cohort. Heart Rhythm (2013) 1.40
Modifying Ventricular Fibrillation by Targeted Rotor Substrate Ablation: Proof-of-Concept from Experimental Studies to Clinical VF. J Cardiovasc Electrophysiol (2015) 1.39
The underuse of overuse research. Health Serv Res (2008) 1.00
Subcutaneous chronic implantable defibrillation systems in humans. J Interv Card Electrophysiol (2012) 0.98
Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy. J Cardiovasc Magn Reson (2011) 0.92
Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs. Heart Fail Rev (2015) 0.89
Sonication of explanted cardiac implants improves microbial detection in cardiac device infections. J Clin Microbiol (2012) 0.88
Analysis of speed, curvature, planarity and frequency characteristics of heart vector movement to evaluate the electrophysiological substrate associated with ventricular tachycardia. Comput Biol Med (2015) 0.87
Abnormal response of superior sinoatrial node to sympathetic stimulation is a characteristic finding in patients with atrial fibrillation and symptomatic bradycardia. Circ Arrhythm Electrophysiol (2011) 0.85
Concealed long QT syndrome and intractable partial epilepsy: a case report. Mayo Clin Proc (2012) 0.85
Causes and prevention of sudden cardiac death in the elderly. Nat Rev Cardiol (2013) 0.85
Altered cardiac rhythm in infants with bronchiolitis and respiratory syncytial virus infection. BMC Infect Dis (2010) 0.83
Risk factor and prediction modeling for sudden cardiac death in women with coronary artery disease. Arch Intern Med (2011) 0.83
Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region. Heart Rhythm (2014) 0.80
[Current status and problems of the entirely subcutaneous ICD (S-ICD®)]. Herzschrittmacherther Elektrophysiol (2013) 0.79
Echocardiographic Predictors of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study and Cardiovascular Health Study. Circ Cardiovasc Imaging (2016) 0.79
The pathway to physician reimbursement for cardiac implantable electronic devices (CIEDs): a history and brief synopsis. J Interv Card Electrophysiol (2012) 0.79
Current Concepts of Premature Ventricular Contractions. J Lifestyle Med (2013) 0.78
Sleep-disordered breathing increases the risk of arrhythmias. J Cardiovasc Med (Hagerstown) (2014) 0.78
Multi-contrast late enhancement CMR determined gray zone and papillary muscle involvement predict appropriate ICD therapy in patients with ischemic heart disease. J Cardiovasc Magn Reson (2013) 0.78
Monitoring biventricular pacing parameters depending on the left ventricle lead configuration. Exp Clin Cardiol (2013) 0.77
A novel mitochondrial DNA deletion in a patient with Kearns-Sayre syndrome: a late-onset of the fatal cardiac conduction deficit and cardiomyopathy accompanying long-term rGH treatment. BMC Pediatr (2013) 0.77
Strategic choices to reduce implantable cardioverter-defibrillator-related morbidity. Nat Rev Cardiol (2010) 0.77
Ventricular fibrillation cardiac arrest due to 5-fluorouracil cardiotoxicity. Tex Heart Inst J (2013) 0.76
Bradycardia-induced Torsade de Pointes - An arrhythmia Less Understood. Indian Pacing Electrophysiol J (2010) 0.76
Is conventional cardiac pacing harmful in patients with normal ventricular function? Arq Bras Cardiol (2013) 0.76
Pauses in the electrocardiogram of a woman with chest pain and lightheadedness. Proc (Bayl Univ Med Cent) (2013) 0.75
Unicuspid unicommissural aortic valve: an extremely rare congenital anomaly. Tex Heart Inst J (2015) 0.75
Long-term Intrinsic Rhythm Evaluation in Dogs with Atrioventricular Block. J Vet Intern Med (2015) 0.75
Delayed intrinsicoid deflection of the QRS complex is associated with sudden cardiac arrest. Heart Rhythm (2015) 0.75
Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm (2009) 0.75
Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study. SAGE Open Med (2016) 0.75
Implantable cardioverter-defibrillator in a patient with dextrocardia situs inversus. Caspian J Intern Med (2016) 0.75
Serum-Based Oxylipins Are Associated with Outcomes in Primary Prevention Implantable Cardioverter Defibrillator Patients. PLoS One (2016) 0.75
Electrophysiology Updates in Adult Congenital Heart Disease. Tex Heart Inst J (2016) 0.75
Endocardial Device Leads in Patients with Patent Foramen Ovale: Echocardiographic Correlates of Stroke/TIA and Mortality. Pacing Clin Electrophysiol (2016) 0.75
The Romhilt-Estes electrocardiographic score predicts sudden cardiac arrest independent of left ventricular mass and ejection fraction. Ann Noninvasive Electrocardiol (2017) 0.75
CRT or CRT-D devices? The case for 'high energy' devices. Heart Fail Rev (2012) 0.75
Low-dose spinal anesthesia in asymptomatic complete heart block without perioperative pacing. J Anesth (2010) 0.75
Cardiac resynchronization in chronic heart failure. N Engl J Med (2002) 17.52
Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med (2009) 12.44
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Universal definition of myocardial infarction. Circulation (2007) 11.69
Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med (2012) 8.84
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med (2009) 8.51
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med (2005) 7.46
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med (2004) 7.12
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA (2006) 5.78
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA (2004) 5.11
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 4.91